⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iva hypopharyngeal carcinoma ajcc v8

Every month we try and update this database with for stage iva hypopharyngeal carcinoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerNCT05172245
Clinical Stage ...
Head and Neck C...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Locally Advance...
Maxillary Sinus...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage III Sinon...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVA Sinon...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Stage IVB Sinon...
Biopsy
Biospecimen Col...
Cisplatin
Computed Tomogr...
Ipatasertib
Magnetic Resona...
Positron Emissi...
Radiation Thera...
18 Years - National Cancer Institute (NCI)
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT04533750
Advanced Head a...
Advanced Hypoph...
Advanced Laryng...
Advanced Oral C...
Advanced Oropha...
Clinical Stage ...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Computed Tomogr...
Fludeoxyglucose...
Intensity-Modul...
Magnetic Resona...
Peposertib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT03258554
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Oral Cavity Squ...
Oropharyngeal S...
Pathologic Stag...
Squamous Cell C...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Cetuximab
Durvalumab
Intensity-Modul...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - National Cancer Institute (NCI)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryNCT02734537
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerNCT03010150
Carcinoma of Un...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Head...
Metastatic Mali...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage I Hypopha...
Stage I Nasopha...
Stage II Hypoph...
Stage II Laryng...
Stage II Nasoph...
Stage II Oropha...
Stage III Hypop...
Stage III Laryn...
Stage III Nasop...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Nasoph...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Nasop...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Nasop...
Stage IVB Oroph...
Biospecimen Col...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckNCT04862650
Clinical Stage ...
Metastatic Head...
Metastatic Hypo...
Metastatic Lary...
Metastatic Oral...
Metastatic Orop...
Pathologic Stag...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Lip a...
Carboplatin
Cemiplimab
Paclitaxel
18 Years - Ohio State University Comprehensive Cancer Center
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck CancerNCT04162873
Clinical Stage ...
Clinical Stage ...
Nasal Cavity an...
Oral Cavity Car...
Pathologic Stag...
Pathologic Stag...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Nasal...
Recurrent Oral ...
Recurrent Oroph...
Stage III Hypop...
Stage III Laryn...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Oropha...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Oroph...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Oroph...
Celecoxib
Placebo
Quality-of-Life...
Questionnaire A...
18 Years - University of Utah
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckNCT04862650
Clinical Stage ...
Metastatic Head...
Metastatic Hypo...
Metastatic Lary...
Metastatic Oral...
Metastatic Orop...
Pathologic Stag...
Recurrent Head ...
Recurrent Hypop...
Recurrent Laryn...
Recurrent Oral ...
Recurrent Oroph...
Squamous Cell C...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVC Hypop...
Stage IVC Laryn...
Stage IVC Lip a...
Carboplatin
Cemiplimab
Paclitaxel
18 Years - Ohio State University Comprehensive Cancer Center
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryNCT02734537
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: